ASCO 2025

time minute
Biotech

Innate says lymphoma data shows anti-KIR3DL2 antibody’s promise

Innate Pharma has produced long-term data showing that its anti-KIR3DL2 antibody has a “sustained effect” against two types of lymphoma.
James Waldron May 23, 2025 5:13am
graphic image of a cube with an arrow nailing the bullseye

ASCO: Cullinan drug sees 35% ORR in pretreated NSCLC

May 22, 2025 5:00pm